-
1.
公开(公告)号:US09340548B2
公开(公告)日:2016-05-17
申请号:US14240636
申请日:2012-08-22
申请人: Christian Brochu , Chantal Grand-Maitre , Marc-Andre Joly , Cyrille Kuhn , Megan Bertrand-Laperle , Marc Pesant
发明人: Christian Brochu , Chantal Grand-Maitre , Marc-Andre Joly , Cyrille Kuhn , Megan Bertrand-Laperle , Marc Pesant
IPC分类号: A61K31/4162 , C07D231/54 , C07D487/04 , C07D513/04 , A61K31/4196 , A61K31/4245 , A61K31/4439 , A61K31/4545 , A61K31/497
CPC分类号: C07D487/04 , A61K31/4162 , A61K31/4196 , A61K31/4245 , A61K31/4439 , A61K31/4545 , A61K31/497 , C07D513/04
摘要: The invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are defined herein, and their use for the treatment of hepatitis C viral infection.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,其中R1,R2,R3和R4如本文所定义,及其用于治疗丙型肝炎病毒感染的用途。
-
公开(公告)号:US08541402B2
公开(公告)日:2013-09-24
申请号:US13463093
申请日:2012-05-03
申请人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
发明人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
IPC分类号: C07D211/38 , C07D213/643 , C07D213/69 , C07D213/81 , C07D215/227 , C07D217/24 , C07D239/38 , C07D239/47 , C07D239/52 , C07D249/04 , C07D277/24 , C07D307/20 , C07D333/32 , C07D401/06 , C07D401/14 , C07D413/06 , C07D417/06 , C07D417/14 , C07D471/04 , A61K31/444
CPC分类号: A61K31/444 , A61K31/5377 , C07D211/38 , C07D213/643 , C07D213/69 , C07D213/81 , C07D215/227 , C07D217/24 , C07D239/34 , C07D239/38 , C07D239/47 , C07D239/52 , C07D249/04 , C07D277/24 , C07D307/20 , C07D333/32 , C07D401/06 , C07D401/12 , C07D401/14 , C07D413/06 , C07D417/06 , C07D417/14 , C07D471/04
摘要: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
-
公开(公告)号:US08912182B2
公开(公告)日:2014-12-16
申请号:US13967922
申请日:2013-08-15
申请人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
发明人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
IPC分类号: C07D401/14 , C07D213/81 , C07D213/643 , C07D239/34 , A61K31/444 , C07D215/227 , C07D217/24 , C07D239/38 , C07D401/06 , C07D417/14 , C07D307/20 , C07D471/04 , C07D239/47 , C07D239/52 , C07D413/06 , C07D249/04 , C07D213/69 , A61K31/5377 , C07D211/38 , C07D417/06 , C07D333/32
CPC分类号: A61K31/444 , A61K31/5377 , C07D211/38 , C07D213/643 , C07D213/69 , C07D213/81 , C07D215/227 , C07D217/24 , C07D239/34 , C07D239/38 , C07D239/47 , C07D239/52 , C07D249/04 , C07D277/24 , C07D307/20 , C07D333/32 , C07D401/06 , C07D401/12 , C07D401/14 , C07D413/06 , C07D417/06 , C07D417/14 , C07D471/04
摘要: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译: 式I化合物:其中X,R2,R3,R3a,R3b,R5和R6如本文所定义,可用作丙型肝炎病毒NS5B聚合酶的抑制剂。
-
公开(公告)号:US08476257B2
公开(公告)日:2013-07-02
申请号:US12808220
申请日:2008-12-03
申请人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
发明人: Pierre L. Beaulieu , Pasquale Forgione , Alexandre Gagnon , Cedrickx Godbout , Marc-Andre Joly , Montse Llinas-Brunet , Julie Naud , Martin Poirier , Jean Rancourt
IPC分类号: A61K31/397 , A61K31/444 , A61K31/44 , A61K31/5377 , A61K31/4439 , A61K31/4545 , A61K31/497 , A61K31/4353 , A61K31/5355 , A61K31/506 , A61K31/551 , C07D401/12 , C07D401/04 , C07D213/643 , C07D413/04 , C07D417/04 , C07D471/04 , A61P31/14
CPC分类号: A61K31/444 , A61K31/5377 , C07D211/38 , C07D213/643 , C07D213/69 , C07D213/81 , C07D215/227 , C07D217/24 , C07D239/34 , C07D239/38 , C07D239/47 , C07D239/52 , C07D249/04 , C07D277/24 , C07D307/20 , C07D333/32 , C07D401/06 , C07D401/12 , C07D401/14 , C07D413/06 , C07D417/06 , C07D417/14 , C07D471/04
摘要: Compounds of formula I: wherein X, R2, R3, R3a, R3b, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
摘要翻译: 式I化合物:其中X,R2,R3,R3a,R3b,R5和R6如本文所定义,可用作丙型肝炎病毒NS5B聚合酶的抑制剂。
-
-
-